Cancer Family
Embryonal Neoplasm
CI-CAN-00000013Explore in graph →
Non-malignant285 active trials7 approved drugs73 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000013Explore in graph →
Clinical trials
1,126 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03874455 | Tazemetostat Expanded Access Program for Adults With Solid Tumors | no longer available | — | — | Epizyme, Inc.INDUSTRY | 0 | Jul 2, 2026 | clinicaltrials |
| NCT07223606 | Fecal Microbiota Transplant for Neuroblastoma in a Single Patient | no longer available | — | — | ProgenaBiomeOTHER | 1 | Nov 3, 2025 | clinicaltrials |
| 131I-Metaiodobenzylguanidine (131I-MIBG) Therapy for Relapsed/Refractory Neuroblastoma |
| no longer available |
| — |
| — |
| University of Texas Southwestern Medical CenterOTHER |
| 1 |
| Dec 11, 2024 |
| clinicaltrials |
| NCT01838187 | Expanded Access Protocol Using 131I-MIBG Therapy +/- Vorinostat for Refractory Neuroblastoma, Pheochromocytoma, or Paraganglioma | no longer available | — | — | Children's Hospital Medical Center, CincinnatiOTHER | 1 | Aug 18, 2023 | clinicaltrials |
| NCT02431715 | 18F-FDOPA PET in Neuroendocrine Tumours | no longer available | — | — | British Columbia Cancer AgencyOTHER | 1 | Feb 21, 2023 | clinicaltrials |
| NCT02075177 | Expanded Access Study of Fenretinide Lym-X-Sorb Plus Ketoconazole in Neuroblastoma | no longer available | — | — | South Plains Oncology ConsortiumNETWORK | 1 | Mar 21, 2022 | clinicaltrials |
| NCT03029481 | Single Patient Expanded Access to Ganitumab for Metastatic Ewing Sarcoma | no longer available | — | — | Jonsson Comprehensive Cancer CenterOTHER | 0 | Mar 28, 2019 | clinicaltrials |
Data updated 22 days agoSource updated Jul 2, 2026source: clinicaltrials